Independent effect of EBV and cigarette smoking on nasopharyngeal carcinoma: A 20-year follow-up study on 9,622 males without family history in Taiwan

Cancer Epidemiology Biomarkers and Prevention

Volumn 18, Issue 4, 2009, Pages 1218-1226

  Hsu, Wan Lun ^a,d   Chen, Jen Yang ^b,d,f   Chien, Yin Chu ^d   Liu, Mei Ying ^e   You, San Lin ^d   Hsu, Mow Ming ^c   Yang, Czau Siung ^b   Chen, Chien Jen ^a,d  

^a Institute of Occupational Medicine and Industrial Hygiene   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^d GENOMICS RESEARCH CENTER   (Taiwan)

^e NATIONAL TAIPEI UNIVERSITY OF NURSING AND HEALTH SCIENCES   (Taiwan)

^f NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

DEOXYRIBONUCLEASE ANTIBODY; ENZYME ANTIBODY; IMMUNOGLOBULIN A ANTIBODY; UNCLASSIFIED DRUG; VIRUS CAPSID ANTIGEN;

ADULT; AGED; ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ARTICLE; CANCER INCIDENCE; CANCER RISK; CIGARETTE SMOKING; COHORT ANALYSIS; CORRELATION ANALYSIS; EPSTEIN BARR VIRUS; FAMILY HISTORY; FOLLOW UP; HAZARD RATIO; HUMAN; MAJOR CLINICAL STUDY; MALE; NASOPHARYNX CARCINOMA; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RISK ASSESSMENT; RISK FACTOR; TAIWAN;

ADULT; ANTIBODIES, VIRAL; ANTIGENS, VIRAL; CAPSID PROTEINS; COHORT STUDIES; EPSTEIN-BARR VIRUS INFECTIONS; FOLLOW-UP STUDIES; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOGLOBULIN A; INCIDENCE; MALE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; QUESTIONNAIRES; RISK FACTORS; SMOKING;

EID: 66649103332     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-08-1175     Document Type: Article

References (49)

1. Busson P, Keryer C, Ooka T, Corbex M. EBV-associated nasopharyngeal carcinomas: from epidemiology to virus-targeting strategies. Trends Microbiol 2004;12:356-360 (Pubitemid 38987821)
2. Cohen JI. Epstein-Barr virus infection. N Engl J Med 2000;343:481-492 (Pubitemid 30646489)
3. Hsu JL, Glaser SL. Epstein-Barr virus-associated malignancies: epidemiologic patterns and etiologic implications. Crit Rev Oncol Hematol 2000;34:27-53. (Pubitemid 30227315)
4. Proceedings of the IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Epstein-Barr Virus and Kaposi's Sarcoma Herpesvirus/Human Herpesvirus 8. Lyon, France, 17-24 June 1997. IARC Monogr Eval Carcinog Risks Hum 1997;70:1-492.
5. Chan AT, Lo YM, Zee B, et al. Plasma Epstein-Barr virus DNA and residual disease after radiotherapy for undifferentiated nasopharyngeal carcinoma. J Natl Cancer Inst 2002;94:1614-1619 (Pubitemid 35378726)
6. de-The G, Lavoue MF, Muenz L. Differences in EBV antibody titres of patients with nasopharyngeal carcinoma originating from high, intermediate and low incidence areas. IARC Sci Publ 1978:471-481
7. Xu J, Ahmad A, D'Addario M, et al. Analysis and significance of antilatent membrane protein-1 antibodies in the sera of patients with EBV-associated diseases. J Immunol 2000;164:2815-2822 (Pubitemid 30115517)
8. Henle W, Ho JH, Henle G, Chau JC, Kwan HC. Nasopharyngeal carcinoma: significance of changes in Epstein-Barr virus-related antibody patterns following therapy. Int J Cancer 1977;20:663-672 (Pubitemid 8218531)
9. Chen JY, Liu MY, Chen CJ, et al. Antibody to Epstein-Barr virus-specific DNase as a marker for the early detection of nasopharyngeal carcinoma. J Med Virol 1985;17:47-49
10. Henle G, Henle W. Epstein-Barr virus-specific IgA serum antibodies as an outstanding feature of nasopharyngeal carcinoma. Int J Cancer 1976;17:1-7.
11. Liu MY, Chang YL, Ma J, et al. Evaluation of multiple antibodies to Epstein-Barr virus as markers for detecting patients with nasopharyngeal carcinoma. J Med Virol 1997;52:262-269 (Pubitemid 27305744)
12. Ji MF, Wang DK, Yu YL, et al. Sustained elevation of Epstein-Barr virus antibody levels preceding clinical onset of nasopharyngeal carcinoma. Br J Cancer 2007;96:623-630 (Pubitemid 46303544)
13. Chien YC, Chen JY, Liu MY, et al. Serologic markers of Epstein-Barr virus infection and nasopharyngeal carcinoma in Taiwanese men. N Engl J Med 2001;345:1877-1882 (Pubitemid 33716562)
14. de-The G. Epidemiology of Epstein-Barr virus and associated diseases in man. In: Roizman B, editor. The herpesviruses. New York, NY: Plenum Press; 1982. p. 25-103.
15. Lin TM, Yang CS, Ho SW, et al. Antibodies to herpes-type virus in nasopharyngeal carcinoma and control groups. Cancer 1972;29:603-609
16. Chen JY, Chen CJ, Liu MY, et al. Antibodies to Epstein-Barr virus-specific DNase in patients with nasopharyngeal carcinoma and control groups. J Med Virol 1987;23:11-21. (Pubitemid 17141493)
17. Chen CJ, Liang KY, Chang YS, et al. Multiple risk factors of nasopharyngeal carcinoma: Epstein-Barr virus, malarial infection, cigarette smoking and familial tendency. Anticancer Res 1990;10:547-553 (Pubitemid 20175636)
18. Lin TM, Chen KP, Lin CC, et al. Retrospective study on nasopharyngeal carcinoma. J Natl Cancer Inst 1973;51:1403-1408
19. West S, Hildesheim A, Dosemeci M. Non-viral risk factors for nasopharyngeal carcinoma in the Philippines: results from a case-control study. Int J Cancer 1993;55:722-727 (Pubitemid 23354883)
20. Cheng YJ, Hildesheim A, Hsu MM, et al. Cigarette smoking, alcohol consumption and risk of nasopharyngeal carcinoma in Taiwan. Cancer Causes Control 1999;10:201-207 (Pubitemid 29290454)
21. Chow WH, McLaughlin JK, Hrubec Z, Nam JM, Blot WJ. Tobacco use and nasopharyngeal carcinoma in a cohort of US veterans. Int J Cancer 1993;55:538-540 (Pubitemid 23328934)
22. Friborg JT, Yuan JM, Wang R, et al. A prospective study of tobacco and alcohol use as risk factors for pharyngeal carcinomas in Singapore Chinese. Cancer 2007;109:1183-1191 (Pubitemid 46435399)
23. Yuan JM, Wang XL, Xiang YB, et al. Non-dietary risk factors for nasopharyngeal carcinoma in Shanghai, China. Int J Cancer 2000;85:364-369 (Pubitemid 30030410)
24. Yu MC, Garabrant DH, Huang TB, Henderson BE. Occupational and other non-dietary risk factors for nasopharyngeal carcinoma in Guangzhou, China. Int J Cancer 1990;45:1033-1039 (Pubitemid 20201571)
25. Nam JM, McLaughlin JK, Blot WJ. Cigarette smoking, alcohol, and nasopharyngeal carcinoma: a case-control study among U.S. whites. J Natl Cancer Inst 1992;84:619-622
26. Vaughan TL, Shapiro JA, Burt RD, et al. Nasopharyngeal cancer in a low-risk population: defining risk factors by histological type. Cancer Epidemiol Biomarkers Prev 1996;5:587-593 (Pubitemid 26265151)
27. Ng TP. A case-referent study of cancer of the nasal cavity and sinuses in Hong Kong. Int J Epidemiol 1986;15:171-175 (Pubitemid 16001815)
28. Armstrong RW, Armstrong MJ, Yu MC, Henderson BE. Salted fish and inhalants as risk factors for nasopharyngeal carcinoma in Malaysian Chinese. Cancer Res 1983;43:2967-2970
29. Henderson BE, Louie E, SooHoo Jing J, Buell P, Gardner MB. Risk factors associated with nasopharyngeal carcinoma. N Engl J Med 1976;295:1101-1106
30. Lee HP, Gourley L, Duffy SW, et al. Preserved foods and nasopharyngeal carcinoma: a case-control study among Singapore Chinese. Int J Cancer 1994;59:585-590 (Pubitemid 24358578)
31. Ning JP, Yu MC, Wang QS, Henderson BE. Consumption of salted fish and other risk factors for nasopharyngeal carcinoma (NPC) in Tianjin, a low-risk region for NPC in the People's Republic of China. J Natl Cancer Inst 1990;82:291-296 (Pubitemid 20097701)
32. Yu MC, Ho JH, Lai SH, Henderson BE. Cantonese-style salted fish as a cause of nasopharyngeal carcinoma: report of a case-control study in Hong Kong. Cancer Res 1986;46:956-961 (Pubitemid 16145462)
33. Chen KP, Wu HY, Yeh CC, Cheng YJ. Color atlas of cancer mortality by administrative and other classified districts in Taiwan area: 1968-1976. Taipei, Taiwan: National Science Council 1979.
34. Chen JY, Chen CJ, Liu MY, et al. Antibody to Epstein-Barr virus-specific DNase as a marker for field survey of patients with nasopharyngeal carcinoma in Taiwan. J Med Virol 1989;27:269-273 (Pubitemid 19125780)
35. Raab-Traub N. Epstein-Barr virus in the pathogenesis of NPC. Semin Cancer Biol 2002;12:431-441 (Pubitemid 35370756)
36. Young LS, Rickinson AB. Epstein-Barr virus: 40 years on. Nat Rev Cancer 2004;4:757-768 (Pubitemid 39331148)
37. Kutok JL, Wang F. Spectrum of Epstein-Barr virus-associated disease. Annu Rev Pathol 2006;1:375-404.
38. Lengauer C, Kinzler KW, Vogelstein B. Genetic instabilities in human cancers. Nature 1998;396:643-649 (Pubitemid 29003936)
39. Mutirangura A, Tanunyutthawongese C, Pornthanakasem W, et al. Genomic alterations in nasopharyngeal carcinoma: loss of heterozygosity and Epstein-Barr virus infection. Br J Cancer 1997;76:770-776 (Pubitemid 27379745)
40. Fang CY, Lee CH, Wu CC, et al. Recurrent chemical reactivations of EBV promote genome instability and enhances tumor progression of nasopharyngeal carcinoma cells. Int J Cancer 2009;124:2016-2025
41. Cho EY, Hildesheim A, Chen CJ, et al. Nasopharyngeal carcinoma and genetic polymorphisms of DNA repair enzymes XRCC1 and hOGG1. Cancer Epidemiol Biomarkers Prev 2003;12:1100-1104 (Pubitemid 37310270)
42. Sixbey JW, Nedrud JG, Raab-Traub N, Hanes RA, Pagano JS. Epstein-Barr virus replication in oropharyngeal epithelial cells. N Engl J Med 1984;310:1225-1230 (Pubitemid 14140362)
43. Sixbey JW, Vesterinen EH, Nedrud JG, et al. Replication of Epstein-Barr virus in human epithelial cells infected in vitro . Nature 1983;306:480-483 (Pubitemid 14235570)
44. Wolf H, Haus M, Wilmes E. Persistence of Epstein-Barr virus in the parotid gland. J Virol 1984;51:795-798 (Pubitemid 14063158)
45. Lin TM, Yang CS, Tu SM, et al. Interaction of factors associated with cancer of the nasopharynx. Cancer 1979;44:1419-1423 (Pubitemid 10197417)
46. IARC monographs on the evaluation of carcinogenic risks to humans. Vol.83. Tobacco smoke and involuntary smoking. Lyon (France): IARC Press; 2004. p. 51-94.
47. Ward MH, Pan WH, Cheng YJ, et al. Dietary exposure to nitrite and nitrosamines and risk of nasopharyngeal carcinoma in Taiwan. Int J Cancer 2000;86:603-609 (Pubitemid 30249868)
48. Yuan JM, Wang XL, Xiang YB, et al. Preserved foods in relation to risk of nasopharyngeal carcinoma in Shanghai, China. Int J Cancer 2000;85:358-363 (Pubitemid 30030409)
49. Hildesheim A, Anderson LM, Chen CJ, et al. CYP2E1 genetic polymorphisms and risk of nasopharyngeal carcinoma in Taiwan. J Natl Cancer Inst 1997;89:1207-1212 (Pubitemid 27350030)